Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1968 1
1970 1
1974 1
1975 1
1976 2
1979 1
1980 2
1981 1
1983 1
1984 2
1985 2
1986 3
1987 1
1988 1
1989 3
1990 4
1991 5
1992 1
1993 6
1994 5
1995 5
1996 7
1997 8
1998 6
1999 8
2000 7
2001 8
2002 9
2003 7
2004 12
2005 14
2006 18
2007 5
2008 9
2009 10
2010 13
2011 10
2012 18
2013 18
2014 17
2015 21
2016 18
2017 21
2018 12
2019 21
2020 13
2021 14
2022 11
2023 10
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

365 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Absence seizure with eyelid myoclonia"
Page 1
International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: Position paper by the ILAE Task Force on Nosology and Definitions.
Specchio N, Wirrell EC, Scheffer IE, Nabbout R, Riney K, Samia P, Guerreiro M, Gwer S, Zuberi SM, Wilmshurst JM, Yozawitz E, Pressler R, Hirsch E, Wiebe S, Cross HJ, Perucca E, Moshé SL, Tinuper P, Auvin S. Specchio N, et al. Epilepsia. 2022 Jun;63(6):1398-1442. doi: 10.1111/epi.17241. Epub 2022 May 3. Epilepsia. 2022. PMID: 35503717
Based on the 2017 Classification of Seizures and Epilepsies, some syndrome names have been updated using terms directly describing the seizure semiology. Epilepsy syndromes beginning in childhood have been divided into three categories: (1) self-limited focal epilep …
Based on the 2017 Classification of Seizures and Epilepsies, some syndrome names have been updated using terms directly describing th …
Genetic Epilepsy Syndromes.
Myers KA. Myers KA. Continuum (Minneap Minn). 2022 Apr 1;28(2):339-362. doi: 10.1212/CON.0000000000001077. Continuum (Minneap Minn). 2022. PMID: 35393962 Review.
PURPOSE OF REVIEW: This article reviews the clinical features, typical EEG findings, treatment, prognosis, and underlying molecular etiologies of the more common genetic epilepsy syndromes. ...Proper diagnosis of the electroclinical syndrome allows for appropriate treatmen …
PURPOSE OF REVIEW: This article reviews the clinical features, typical EEG findings, treatment, prognosis, and underlying molecular e …
Epilepsy With Eyelid Myoclonia (Jeavons Syndrome).
Zawar I, Knight EP. Zawar I, et al. Pediatr Neurol. 2021 Aug;121:75-80. doi: 10.1016/j.pediatrneurol.2020.11.018. Epub 2020 Dec 1. Pediatr Neurol. 2021. PMID: 34167046 Review.
We update the management strategies and describe tools that may predict seizure persistence. Epilepsy with eyelid myoclonias, or Jeavons syndrome, is an idiopathic generalized epilepsy characterized by the triad of eyelid myoclonia with or witho …
We update the management strategies and describe tools that may predict seizure persistence. Epilepsy with eyelid myocl …
Sepsis-associated encephalopathy.
Gofton TE, Young GB. Gofton TE, et al. Nat Rev Neurol. 2012 Oct;8(10):557-66. doi: 10.1038/nrneurol.2012.183. Epub 2012 Sep 18. Nat Rev Neurol. 2012. PMID: 22986430 Review.
The severity of SAE can range from mild delirium to deep coma. Seizures and myoclonus are infrequent and cranial nerves are almost always spared, but most severe cases have an associated critical illness neuromyopathy. ...Recent evidence for SAE pathophysiology is o …
The severity of SAE can range from mild delirium to deep coma. Seizures and myoclonus are infrequent and cranial nerves are al …
Update on the management of status epilepticus.
Rossetti AO, Alvarez V. Rossetti AO, et al. Curr Opin Neurol. 2021 Apr 1;34(2):172-181. doi: 10.1097/WCO.0000000000000899. Curr Opin Neurol. 2021. PMID: 33664203 Review.
The recently published ESETT trial provides high-level evidence regarding the equivalence of fosphenytoin, valproate, and levetiracetam as a second-line option. Myoclonus or epileptiform transients on electroencephalography occur in up to 1/3 of patients surviving a cardia …
The recently published ESETT trial provides high-level evidence regarding the equivalence of fosphenytoin, valproate, and levetiracetam as a …
Cefepime-induced neurotoxicity: a systematic review.
Payne LE, Gagnon DJ, Riker RR, Seder DB, Glisic EK, Morris JG, Fraser GL. Payne LE, et al. Crit Care. 2017 Nov 14;21(1):276. doi: 10.1186/s13054-017-1856-1. Crit Care. 2017. PMID: 29137682 Free PMC article. Review.
Neurotoxic symptoms include depressed consciousness, encephalopathy, aphasia, myoclonus, seizures, and coma. Data suggest that up to 15% of ICU patients treated with cefepime may experience these adverse effects. ...Search terms included cefepime, neurotoxicity, enc …
Neurotoxic symptoms include depressed consciousness, encephalopathy, aphasia, myoclonus, seizures, and coma. Data suggest that …
Parkinson's disease - genetic cause.
Cherian A, K P D, Vijayaraghavan A. Cherian A, et al. Curr Opin Neurol. 2023 Aug 1;36(4):292-301. doi: 10.1097/WCO.0000000000001167. Epub 2023 May 24. Curr Opin Neurol. 2023. PMID: 37366140 Review.
X-linked parkinsonism manifests at a young age accompanied by many (atypical) features such as intellectual disability, spasticity, seizures, myoclonus, dystonia, and have poor response to levodopa. ...In the near future, genetic discoveries in Parkinson's disease w …
X-linked parkinsonism manifests at a young age accompanied by many (atypical) features such as intellectual disability, spasticity, seizu …
The best evidence for progressive myoclonic epilepsy: A pathway to precision therapy.
Orsini A, Valetto A, Bertini V, Esposito M, Carli N, Minassian BA, Bonuccelli A, Peroni D, Michelucci R, Striano P. Orsini A, et al. Seizure. 2019 Oct;71:247-257. doi: 10.1016/j.seizure.2019.08.012. Epub 2019 Aug 23. Seizure. 2019. PMID: 31476531 Free PMC article. Review.
PMEs may have infancy, childhood, juvenile or adult onset, but usually present in late childhood or adolescence, at variance from epileptic encephalopathies, which start with polymorphic seizures in early infancy. Neurophysiologic recordings are suited to describe faithful …
PMEs may have infancy, childhood, juvenile or adult onset, but usually present in late childhood or adolescence, at variance from epileptic …
Hashimoto's encephalopathy : epidemiology, pathogenesis and management.
Mocellin R, Walterfang M, Velakoulis D. Mocellin R, et al. CNS Drugs. 2007;21(10):799-811. doi: 10.2165/00023210-200721100-00002. CNS Drugs. 2007. PMID: 17850170 Review.
The clinical presentation may involve a relapsing and remitting course and include seizures, stroke-like episodes, cognitive decline, neuropsychiatric symptoms and myoclonus. ...
The clinical presentation may involve a relapsing and remitting course and include seizures, stroke-like episodes, cognitive d …
Lafora disease.
Turnbull J, Tiberia E, Striano P, Genton P, Carpenter S, Ackerley CA, Minassian BA. Turnbull J, et al. Epileptic Disord. 2016 Sep 1;18(S2):38-62. doi: 10.1684/epd.2016.0842. Epileptic Disord. 2016. PMID: 27702709 Free PMC article. Review.
Lafora disease (LD) is an autosomal recessive progressive myoclonus epilepsy due to mutations in the EPM2A (laforin) and EPM2B (malin) genes, with no substantial genotype-phenotype differences between the two. ...With the exception of a few missense mutations LD is clinica …
Lafora disease (LD) is an autosomal recessive progressive myoclonus epilepsy due to mutations in the EPM2A (laforin) and EPM2B (malin …
365 results